Dr. Matthew A. Sparks, eAJKD Advisory Board member

Matthew A. Sparks, MD, is a physician-scientist in the Division of Nephrology at Duke University Medical Center and the Durham VA Medical Center in Durham, NC. He completed his residency in internal medicine at the University of Arkansas for Medical Sciences in Little Rock, AR where he also served as chief resident. He then completed his nephrology fellowship training at Duke with additional training in hypertension research. His lab is interested in understanding how both the renin angiotensin and prostanoid systems regulate blood pressure by altering blood flow to the kidney. The lab utilizes a combination of physiologic and molecular techniques in genetically modified mice to probe questions about how changes in the micro circulation of the kidney alter sodium excretion. The overarching goal of this research is to identify novel mechanisms to target drug therapy for patients with hypertension. His research is funded by a career development award from the Department of Veterans Affairs Office of Research and Development (BXIK2BX002240) and a Scientist Development Grant from the American Heart Association. Click here to view his publications in pubmed. He is also interested in enhancing medical education in nephrology. He has served on the editorial board of ASN Kidney News and as past deputy editor of Renal Fellow Network. His publications include using social media in nephrology education and he is interested in finding novel ways to share and understand medical research and information. He is a fellow of the American Society of Nephrology (ASN), the National Kidney Foundation (NKF) and a member of the ASN education committee.

A Model for Funding Young Physician-Researchers in Nephrology

grants folder

Having viable funding opportunities for early career investigators is vital for sustaining a cadre of researchers interested in studying and advancing any field of medicine. This is of particular concern in nephrology where NIH funding for kidney disease research lags behind many other chronic diseases. A recent analysis reported in ASN Kidney News determined that […]

Top 10 eAJKD Posts From 2014

eAJKD Advisory Board member, Dr. Matt Sparks, gathered the top 10 eAJKD posts from 2014 (in reverse order): 10. Kidney Week 2014: New Drug for Hyperkalemia by Dr. Dena Rifkin 9. Welcome to Nephmadness 2014 by Drs. Matt Sparks, Joel Topf, Kenar Jhaveri, Warren Kupin, and Edgar Lerma 8. Recovery time from dialysis session? Does it Matter? by Dr. Veeraish Chauhan […]

Podocyturia in Healthy Individuals Shows Markers of De-differentiation

Maestroni et al RL AJKD fig 2

The podocyte has emerged as the focus of intense investigation for kidney researchers. This cell is located at the key transition point in the glomerulus where the plasma is filtered through the basement membrane to enter the urinary space to begin the journey to become urine. Over the last 10 years, mutations in multiple genes […]

Recap of eAJKD’s coverage of Kidney Week 2014


Check out all of the coverage of the American Society of Nephrology’s 2014 Kidney Week in Philadelphia, Pennsylvania, by eAJKD’s Kenar Jhaveri, Edgar Lerma, Matt Sparks, Joel Topf, Craig Gordon, Magdalena Madero, Parmjeet Randhawa, Helbert Rondon, and AJKD In a Few Words Feature Editor Dena Rifkin: Social Media Spotlight The Kidney-Liver Service New Drug for Hyperkalemia Preserving Residual Kidney Function in ESRD […]

Kidney Week 2014 Late Breaking Abstracts: HALT-PKD


The results of the two HALT-PKD trials (Early PKD and Late PKD) were reported during the late breaking clinical trials session at Kidney Week 2014 and simultaneously published in NEJM. We still have many unanswered questions about how to treat patients with autosomal dominant polycystic kidney disease (PKD). However, the last few ASN sessions have […]

Kidney Week 2014: Social Media Spotlight


Kidney Week 2014 featured a fantastic social media special session. Social media is emerging as great tool for kidney care specialists to exchange ideas and rapidly discuss emerging medical discoveries and pertinent issues related to nephrology and medicine. The session was entitled Tweets, Likes, and Blogs: How to Use Social Media for Your Patients and Your […]

miR-186 in FSGS: Entering a New Era in Biomarkers

The hunt for novel biomarkers for the diagnosis and monitoring of kidney diseases has intensified over the last decade, and several important advances are beginning to make their way into clinical medicine. Most notable is anti-PLA2R antibody testing for the diagnosis and monitoring of membranous nephropathy. In fact, a clinical test for anti-PLA2R antibodies was […]

The Name Game: An Improved Search Algorithm for Finding CKD Literature


What is in a name? The field of nephrology has grown accustomed to name changes. It seems we are never satisfied with only one name. Is it the Renal Division or the Division of Nephrology? How about Renal Week, or what we now call Kidney Week? What used to be acute renal failure is now […]

Page the Renal fellow, please!


Much has been made about the decline of physicians entering a career in nephrology over the last decade. To be fair, this is a predicament with multiple factors at play. One such factor is work-life balance. It has recently been shown that ~50% of nephrology fellows show some degree of dissatisfaction in their career choice secondary […]

Test Your Knowledge: GFR Estimation


Understanding the principles of glomerular filtration rate (GFR) estimation is critical to clinical practice and research. A recent article by Levey et al in AJKD discusses the physiology of glomerular filtration, and the application of GFR estimation for clinical care and public health. The following questions will test your knowledge on this important topic: 1. […]


Get every new post delivered to your Inbox.

Join 5,289 other followers